Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. Urol Oncol. 2002 Jul-Aug; 7(4):153-7.